US Patent 7566719 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
Patent 7566719 was granted and assigned to Enanta Pharmaceuticals on July, 2009 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 6, 2008
Date of Patent
July 28, 2009
Patent Application Number
12043421
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7566719 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
